The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

After a presidential campaign characterized by anti-trans slogans — such as ads stating, “Kamala is for they/them, President ...